ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Does Pancreas Transplantation for the Patients with Diabetes Showed Significant Survival Benefit?

J. Choi, J. Jung, S. Chun, S. Shin, Y. Kim, D. Han.

Department of General Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Meeting: 2017 American Transplant Congress

Abstract number: C222

Keywords: Pancreas transplantation, Survival, Waiting lists

Session Information

Session Name: Poster Session C: Pancreas and Islet (Auto and Allo) Transplantation

Session Type: Poster Session

Date: Monday, May 1, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Background : Pancreas transplantation was considered a therapeutic option for patients with complicated DM. However, in the past decade, the annual number of PT performed in the United States has steadily declined, despite of the setting of improvements in graft and patient survival outcomes and transplanting higher-risk patients. In this study, we analyzed our patients on the waiting list for PT(PTA,SPK,SPLK,PAK) and who received PT already to compare patients' survival

Methods : Retrospective analysis was performed on patients in our center between February 2000 and December 2015. 503 patients (PTA n=116, SPK/SPLK n-303, PAK n=84) on the waiting list and 280 recipients (PTA n=89, SPK, SPLK n=155, PAK n=36) received PT were enrolled. All patients receiving or waiting multi-organ transplant(other than SPK./SPLK) were excluded. Their clinical characteristics and all-cause mortality were analyzed.

Results: 11.9% (60/503) on the waiting list and 4.3% (12/280) on PT group were died. Overall survival of patients was significantly higher in waiting list group for the first year (99.3% vs. 97.8%). However, after then, those were significantly higher in PT group (92.8%, vs, 95.5% in 3 year; 83.1% vs. 94.5 in 7 year, p=0.001). Transplant patient 1- and 3- year survival rates were 99.1 and 97.3, while those on the waiting list were 97.6% and 94.6%, respectively for PTA (p=0.644). For PAK group 1- and 5 year survival rates were 98.8% and 95.9%, while those on waiting list were 100% and 94.7% respectively (p=0.658). Overall relative risk of all-cause mortality for transplant recipients (compared with patients with patients waiting the same procedure) was 1.385 (95% CI, 0.346-5.547; p=0.433) for PTA, 0.614 (95% CI, 0.071-5.292 ; p=0.654) for PAK. However, for SPK/SPLK, that was 0.196(95% CI, 0.088-0.435; p<0.001).

Conclusion :SPK or SPLK can offers considerable survival benefits, despite of their relatively long waiting time, when comparing those of the patients with diabetes on waiting list, especially from 1 year. However, for solitary pancreas transplantation, we should give better attentions to weigh the potential benefit of surgery or waiting.

CITATION INFORMATION: Choi J, Jung J, Chun S, Shin S, Kim Y, Han D. Does Pancreas Transplantation for the Patients with Diabetes Showed Significant Survival Benefit? Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Choi J, Jung J, Chun S, Shin S, Kim Y, Han D. Does Pancreas Transplantation for the Patients with Diabetes Showed Significant Survival Benefit? [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/does-pancreas-transplantation-for-the-patients-with-diabetes-showed-significant-survival-benefit/. Accessed May 10, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences